Slovenian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
chymopapain/preobčutljivost
Povezava se shrani v odložišče
Stran 1 iz 28 rezultatov
[Allergy to chymopapain: value of predictive tests before chemonucleolysis].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
It is possible to treat vertebral disc hernias by chemonucleolysis because of the enzymatic properties of chymopapain extracted from Carica papaya. But, 1% of the general population would seem to have a latent sensitivity to this protein, and would thus be at risk of presenting life-threatening
[Sensitization to chymopapain in patients treated with chemonucleolysis].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Chemonucleolysis (intradisk administration of chymopapain) is a procedure to treat intervertebral disk hernia. Recently, its use has been questioned due to the development of anaphylactic reactions in patients sensitized to chymopapain. The prevalence of sensitization to chymopapain has
Reactivity of IgE and IgG serum levels to chymopapain after chemonucleolysis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Patients suffering from herniated lumbar intervertebral disks can currently be treated by chemonucleolysis. This procedure involves reducing the nucleus pulposus by injecting chymopapain into the affected intervertebral disk. A small percentage of the patients who undergo this treatment experience
Pretreatment serum levels of IgE to chymopapain in reactive patients.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Discolysis (chemonucleolysis) with chymopapain, the proteolytic enzyme, is currently being used in the treatment of herniated lumbar discs. Of the patients receiving treatment, approximately 1% experience an anaphylactic reaction. This reaction is thought to be mediated by IgE antibodies to
Prospective comparative study of intradiscal high-dose and low-dose collagenase versus chymopapain.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The mixed results of two studies on intradiscal therapy with collagenase versus chymopapain are presented. The first study was performed from January 1983 to March 1984 and consisted of 71 patients treated with collagenase injection (600 ABC units) and 93 patients treated with chymopapain injection
Update on chymopapain.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Chemonucleolysis with chymopapain is accepted by many surgeons as a reasonable alternative to lumbar diskectomy for the treatment of lumbar disk disease. Approximately 70 to 75 per cent of carefully selected patients are successfully treated following this therapy, but extreme care must be exercised
Brain Activation in a Cynomolgus Macaque Model of Chymopapain-Induced Discogenic Low Back Pain: A Preliminary Study.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
[Clinical experience with intradisk chymopapain administration in lumbar intervertebral disk displacement].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
In a retrospective study, complications following 157 chemonucleolyses (CNL) with chymopapain in 139 patients wer studied and the kind of pathological changes as found in the operation after CNL compared with those found in patients who were operated on because free sequesters were suspected on
Anaphylactic shock associated with chymopapain skin test. A case report and review of the literature.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The allergic response to chymopapain intradiscal therapy has been well documented. The most serious of these reactions is anaphylactic shock, which may result in death. Various screening methods, including skin tests, have been proposed to identify susceptible patients. Anaphylactic shock occurred
Prospective evaluation of chymopapain sensitivity in patients undergoing chemonucleolysis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Immediate anaphylactic reactions after intradiscal chymopapain (CP) injection may occur in 1% of patients undergoing chemonucleolysis (CN). Skin prick testing to CP (10 mg/ml), a prescreening history, and CP serum-specific IgE determinations by the RAST method were performed in order to identify
Incidence and risk factors for latent sensitization to chymopapain: predictive skin-prick tests in 700 candidates for chemonucleolysis.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Seven hundred patients were investigated prospectively before undergoing chemonucleolysis. A past history of allergy and/or previous exposure to papain, either in food, beverages or drugs, was sought, and a skin-prick test with chymopapain was performed. Based on the results obtained, the subjects
Proteins: chymopapain and insulin.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
We studied clinical and immunologic aspects of the reactions to two newly introduced drugs, chymopapain and human recombinant deoxyribonucleic acid insulin (HI), in patients demonstrating allergies to one of these two drugs. We then used this information to improve our ability to diagnose and
Treatment of sciatica. A comparative survey of complications of surgical treatment and nucleolysis with chymopapain.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Chymopapain in the treatment of sciatica by chemonucleolysis has become widespread in the United States and Europe since the approval of this drug for general use by the Food and Drug Administration. Potentially, the increased use of this drug by surgeons with relatively little experience could be
Evaluation of papain/chymopapain cross allergenicity.
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Recent clinical evidence suggests that papain and chymopapain may share common allergenicity. Patients that become sensitized to papain may subsequently experience an allergic reaction when they are exposed to chymopapain. This study demonstrates a cross antigenicity between the proteolytic enzyme
[Latex-papaya syndrome: an infrequent association].
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
Latex-fruit syndrome (LFS) is characterized by allergy to latex and plants. Papain, chymopapain, caricaine and class I chitinases are papaya's most allergenic proteins. The similarity between latex hevein epitopes and papaya class I chitinases might explain the latex-papaya syndrome (LPS).
To
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
- Deluje v 55 jezikih
- Zeliščna zdravila, podprta z znanostjo
- Prepoznavanje zelišč po sliki
- Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
- Preberite znanstvene publikacije, povezane z vašim iskanjem
- Iščite zdravilna zelišča po njihovih učinkih
- Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah
